Alternate Splicing in Toll-like Receptor Signaling
Author Information
Author(s): Christine A Wells, Alistair M Chalk, Alistair Forrest, Darrin Taylor, Nic Waddell, Kate Schroder, S Roy Himes, Geoffrey Faulkner, Sandra Lo, Takeya Kasukawa, Hideya Kawaji, Chikatoshi Kai, Jun Kawai, Shintaro Katayama, Piero Carninci, Yoshihide Hayashizaki, David A Hume, Sean M Grimmond
Primary Institution: Griffith University
Hypothesis
How common is alternate splicing in the Toll-like receptor signaling pathway?
Conclusion
The study found that members of the Toll-like receptor signaling pathway are highly alternatively spliced, producing many novel proteins that can alter inflammatory outcomes.
Supporting Evidence
- A total of 256 variant transcripts were identified in the study.
- The expression of variant transcripts was assessed using custom-designed splicing arrays.
- Functional testing showed that variant proteins can alter macrophage survival.
- The study suggests a common role for variant proteins in inflammatory signaling.
Takeaway
This study shows that the immune system can create many different proteins from the same gene, which helps it respond better to infections.
Methodology
The study used a systematic analysis of the FANTOM3 mouse cDNA dataset and splicing arrays to assess the expression of variant transcripts.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website